Spinal anaesthesia for patients with coronavirus disease 2019 and possible transmission rates in anaesthetists: retrospective, single-centre, observational cohort study

被引:82
|
作者
Zhong, Qi [1 ]
Liu, Yin Y. [1 ]
Luo, Qiong [1 ]
Zou, Yu F. [1 ]
Jiang, Hai X. [1 ]
Li, Hui [1 ]
Zhang, Jing J. [1 ]
Li, Zhen [1 ]
Yang, Xin [1 ]
Ma, Min [1 ]
Tang, Li J. [1 ]
Chen, Ying Y. [1 ]
Zheng, Feng [1 ]
Ke, Jian J. [1 ]
Zhang, Zong Z. [1 ]
机构
[1] Wuhan Univ, Zhongnan Hosp, Dept Anaesthesiol, Wuhan, Hubei, Peoples R China
关键词
COVID-19; perioperative clinical characteristics; spinal anaesthesia; surgery;
D O I
10.1016/j.bja.2020.03.007
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: The safety of performing spinal anaesthesia for both patients and anaesthetists alike in the presence of active infection with the novel coronavirus disease 2019 (COVID-19) is unclear. Here, we report the clinical characteristics and outcomes for both patients with COVID-19 and the anaesthetists who provided their spinal anaesthesia. Methods: Forty-nine patients with radiologically confirmed COVID-19 for Caesarean section or lower-limb surgery undergoing spinal anaesthesia in Zhongnan Hospital, Wuhan, China participated in this retrospective study. Clinical characteristics and perioperative outcomes were recorded. For anaesthesiologists exposed to patients with COVID-19 by providing spinal anaesthesia, the level of personal protective equipment (PPE) used, clinical outcomes (pulmonary CT scans), and confirmed COVID-19 transmission rates (polymerase chain reaction [PCR]) were reviewed. Results: Forty-nine patients with COVID-19 requiring supplementary oxygen before surgery had spinal anaesthesia (ropivacaine 0.75%), chiefly for Caesarean section (45/49 [91%]). Spinal anaesthesia was not associated with cardiorespiratory compromise intraoperatively. No patients subsequently developed severe pneumonia. Of 44 anaesthetists, 37 (84.1%) provided spinal anaesthesia using Level 3 PPE. Coronavirus disease 2019 infection was subsequently confirmed by PCR in 5/44 (11.4%) anaesthetists. One (2.7%) of 37 anaesthetists who wore Level 3 PPE developed PCR-confirmed COVID19 compared with 4/7 (57.1%) anaesthetists who had Level 1 protection in the operating theatre (relative risk reduction: 95.3% [95% confidence intervals: 63.7e99.4]; P<0.01). Conclusions: Spinal anaesthesia was delivered safely in patients with active COVID-19 infection, the majority of whom had Caesarean sections. Level 3 PPE appears to reduce the risk of transmission to anaesthetists who are exposed to mildly symptomatic surgical patients.
引用
收藏
页码:670 / 675
页数:6
相关论文
共 50 条
  • [1] Spinal anaesthesia for patients with coronavirus disease 2019 and possible transmission rates in anaesthetists: retrospective, single centre, observational cohort study (vol 124, pg 670, 2020)
    Zhong, Qi
    Liu, Yin Y.
    Luo, Qiong
    Zou, Yu F.
    Jiang, Hai X.
    Li, Hui
    Zhang, Jing J.
    Li, Zhen
    Yang, Xin
    Ma, Min
    Tang, Li J.
    Chen, Ying Y.
    Zheng, Feng
    Ke, Jian J.
    Zhang, Zong Z.
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 2020, 125 (03) : 408 - 408
  • [2] The clinical characteristics and outcomes of patients with diabetes and secondary hyperglycaemia with coronavirus disease 2019: A single-centre, retrospective, observational study in Wuhan
    Zhang, Yang
    Li, Haichao
    Zhang, Jian
    Cao, Yedi
    Zhao, Xue
    Yu, Nan
    Gao, Ying
    Ma, Jing
    Zhang, Hong
    Zhang, Junqing
    Guo, Xiaohui
    Liu, Xinmin
    [J]. DIABETES OBESITY & METABOLISM, 2020, 22 (08): : 1443 - 1454
  • [3] Impact of Coronavirus Disease 2019 on Clinical Characteristics in Patients With Lung Cancer: A Large Single-Centre Retrospective Study
    Zhang, Yu
    Li, Jie
    Li, Zhi-Ke
    Yang, Xiyue
    Bai, Jie
    Liu, Lihua
    Dai, Tangzhi
    Feng, Gang
    Li, Qiu
    Du, Xiaobo
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [4] Analysis of possible risk predictors in patients with coronavirus disease 2019: a retrospective cohort study
    Nienkotter, Beatriz
    Gambetta, Marcelo Vier
    da Rocha, Franciani Rodrigues
    Medeiros, Erick Dieter
    Schweitzer, Israel
    Prado, Fernanda
    Deschamps, Paulo Sergio da Silva
    [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2023, 69 (05):
  • [5] Response to "Analysis of possible risk predictors in patients with coronavirus disease 2019: a retrospective cohort study"
    Amjad, Marium
    [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2024, 70 (03):
  • [6] Neutropenia in inflammatory bowel disease patients on TNF inhibitors: A single-centre, retrospective cohort study
    AlAskar, D.
    Mais, A.
    Al Sulais, E.
    Alameel, T.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S547 - S548
  • [7] Management of cystinuric patients: An observational, retrospective, single-centre analysis
    Ahmed, Kamran
    Khan, Mohammad Shamim
    Thomas, Kay
    Challacombe, Ben
    Bultitude, Matthew
    Glass, Jonathan
    Tiptaft, Richard
    Dasgupta, Prokar
    [J]. UROLOGIA INTERNATIONALIS, 2008, 80 (02) : 141 - 144
  • [8] Azvudine and mortality in patients with coronavirus disease 2019: A retrospective cohort study
    Liu, Bin
    Yang, Mingjin
    Xu, Li
    Li, Yishi
    Cai, Jing
    Xie, Bo
    Zong, Kaican
    Guo, Shuliang
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 124
  • [9] Family companion between patients with coronavirus disease 2019: a retrospective observational study
    Liu Ye
    Cheng Qin
    Wang Jun-Hong
    Li Shu
    Tian Ci
    Li Yu-Xuan
    Zhang Wen-Hui
    Shen Ning
    Qiao Jie
    [J]. 中华医学杂志(英文版), 2020, 133 (20) : 2507 - 2509
  • [10] Barotrauma in patients with severe coronavirus disease 2019-retrospective observational study
    Bajto, Petra
    Saric, Ivana
    Bugarin, Josipa Domazet
    Delic, Nikola
    Dosenovic, Svjetlana
    Ilic, Darko
    Stipic, Sanda Stojanovic
    Duplancic, Bozidar
    Saric, Lenko
    [J]. JOURNAL OF THORACIC DISEASE, 2023, 15 (10) : 5297 - 5306